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1. Clinical history
A 7-month-old female patient with failure to thrive and 
nonspecific metabolic disorders was seen in the gastroen-
terology clinic of the Hospital Infantil de México Federico 
Gómez (HIMFG).
1.1. History
Her mother was 21 and her father 24 years old. She had a 
3-year-old brother; they had not known disease neither 
evidence of consanguinity. She was breastfed for a month 
and complementary feeding since 5 months of age.
DEVELOPMENT. She had incomplete head control, did 
not roll over and did not sit. She attended rehabilitation 
therapy.
INMUNIZATIONS. BCG, a dose of acelullar pentavalent 
vaccine (DPaT+VIP+Hib) and two doses of hepatitis B vac-
cines.
She was the product of the second pregnancy with pre-
natal care since the first month of pregnancy. The mother 
received supplementary iron and folic acid. She was born in 
a hospital at 40 weeks of gestation, weight 3,050 g, height 
49 cm, and an Apgar score of 8/9. She was discharged in the 
second day of life without the mother, who remained hospi-
talized five days because of hypovolemic shock.
At 2 months of age, she was hospitalized for 15 days 
because of an acute gastroenteritis with dehydration; she 
received antibiotics and a red blood cell transfusion be-
cause of anemia. Three months later, she was hospitalized 
again because of an increase of the abdominal circumfer-
ence. An abdominal ultrasonography detected hepatomeg-
aly, so she was sent to HIMFG. The referral note registered 
a weight of 4,800 g, a height of 57 cm, a head circumfer-
ence of 41 cm and the liver edge at 4-3-4 cm below costal 
margin.
On admission to HIMFG the abdominal circumference 
had increased from 46 to 50 cm in 8 days, and abdominal 
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wall collateral vessels were visible. She had jaundice no-
ticeable in mucous membranes and sclera which started 4 
days prior to her arrival.
In the next two days, she showed progressive neuro-
logical deterioration: hypoactivity, drowsiness and stupor, 
increase in sleeping periods without response to awaken-
ing efforts. The following data were recorded: weight 
4,000 g, height 61 cm, heart rate 153/min, respiratory rate 
30/min, blood pressure 80/50 mmHg, temperature 37.7°C, 
abdominal circumference 53 cm, Glasgow coma score 
(GCS) of 9.
Her apparent age was under her chronological age. She 
was drowsy, with a normal head, normal pupils and icteric 
sclera. She had no lymphadenopathies, respiratory move-
ments were asymmetric. Lungs were well ventilated. 
Heart sounds were increased in frequency with no mur-
murs. The abdomen was distended due to ascites; it was 
soft, compressible, and painless, and peristalsis could be 
heard. Extremities were normal, with good capillary refill, 
and adequate pulse intensity. Painful stimulation was 
needed for eye opening, verbal and motor response.
Ophthalmological exploration showed bilateral nuclear 
cataract.
The patient remained in critical care for 2 months. On 
admission, an endotracheal tube was placed, and although 
it could be removed, the patient developed ventilatory 
impairment associated with the restrictive ascites, abnor-
mal fluid distribution and nosocomial infectious events. 
The ventilatory strategy was dynamic and included high 
frequency ventilation at the end of her stay.
She presented several events of hemodynamic instabil-
ity, some related to nosocomial infection. She required 
management with vasopressors and inotropes. Ampicillin 
resistant Enterococcus faecium was identified in a blood 
culture. She received several broad-spectrum antibiotics 
at meningeal doses because of the impossibility to per-
form a lumbar puncture to rule out central nervous system 
infection. Given her risk factors and the presence of hy-
phae in urine, antifungal coverage was also included.
From a metabolic point of view, the patient coursed 
with hyponatremia of difficult management and persistent 
hypoglycemia. On the hematologic, she had anemia with 
anisocytosis, acanthocytosis and macrocytosis in periph-
eral blood smear. She had bleeding form mucous mem-
branes associated with thrombocytopenia, liver failure 
coagulopathy and disseminated intravascular coagulation, 
which was managed with vitamin K, plasma and cryopre-
cipitate transfusions (Table 1).
Within the approach for hepatopathy, portal hyperten-
sion without splenomegaly was identified. She continued 
with increasing abdominal distention, elevated ami-
notransferases and ammonium, hypoglycemia, with no 
acholic stools neither choluria (Table 1). Structural and 
infectious causes of liver disease were ruled out (Table 2). 
Table 1 General laboratory tests.
Hb Hct Leu Neu Immature Neu Lymph Mon Alfa 1 antitrypsin
7.10 g/dl 22.8% 37,300 42% 8% 24% 26% 106 mg/dl
PT PTT INR LDH Colesterol Triglycerides HDL LDL
31.6” >120” 2.43 477 U 67 mg/dl 38 mg/dl 33 mg/dl 26.4 mg/dl
BUN Creat DB IB TB ALT AST DHL Alb T Prot
19 mg/dl 0.5 mg/dl 10.6 mg/dl 12.7 mg/dl 23.3 mg/dl 27 U 40 U 524 U 4 g/dl 5.2 g/dl
BD BI BT ALT AST Alb Prot T Gluc Ammon GGT
9.9 mg/dl 12.7 mg/dl 22.6 mg/dl 31 U 75 U 3 g/dl 8.3 g/dl 61 mg/dl 144-259 µmol/l 27 U
Hb, hemoglobin; Hct, hematocrit; Leu, leucocytes; Neu, neutrophils; Lymph, limphocytes; Mon, monocytes; PT, protrombin time; PTT, 
partial tromboplastin time; LDH, lactic dehydrogenase; HDL, high density lipoproteins; LDL, low density lipoprotein; BUN, blood urea 
nitrogen; Creat, creatinin; DB, direct bilirubin; IB, indirect bilirubin; TB, total bilirubin; ALT, alanine aminotransferase; AST, aspartate 
aminotransferase; Alb, albumin; TProt, total protein; Gluc, glucose; Ammon, ammonia; GGT, gammaglutamyl transferase.
Table 2 Serologic tests.
HAV HBV HCV HIV Toxoplasma Rubella
IgM IgG Ag Sup Ac Antigen Sup  
-
 
-
IgG/IgG IgG/IgM
- + - + - <10 U/ml
CMV HSV I HSV II Ag. EB
IgG IgM IgG IgM IgG IgM IgG EBNA
- - + - + <10 U/ml <10 U/ml <5.0 U/ml
Total IgA Total IgE Total IgM Total IgG 
10.9 g/dl <17.3 UI/ml 260 mg/dl 1,120 mg/dl
HAV, hepatitis A virus; HBV, hepatitis B virus; HCV, hepatitis C virus; HIV, human immunodeficiency virus; CMV, cytomegalovirus; HSV I, 
herpes simplex virus I; HSV II, herpes simplex virus II; EB, Epstein-Barr.
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Amino acid and acylcarnitine profiles were reported as 
normal. Thyrotorpin (TSH) was 0.9mUI/ml and 25-OH vita-
min D, 27.7 ng/ml.
GCS was 12 while not on sedatives. Management includ-
ed sodium restriction to 2 mEq/kg/d, spironolactone 6 
mg/kg/d, furosemide 1 mg/kg/d, lactulose 1 ml/kg/d, ri-
faximin 20 mg/kg/d, vitamin K 10 mg/d, plasma and cryo-
precipitate transfusion and protein restriction. Albumin 
infusion at 1 g/kg was administered for ascites to manage 
the restrictive ventilatory pattern.
Renal function deteriorated: serum creatinine in-
creased to 0.7 mg/dl (Table 3), while fractional excretion 
of sodium (FeNa) was 0.6% and urinary sodium 6 mmol/l. 
Hepatorrenal syndrome was diagnosed and was managed 
with terlipressin and albumin infusion. The abdominal 
pressure was 13 cmH2O, and a therapeutic paracentesis 
was performed with 1,200 ml drainage, which improved 
renal function.
The algology service prescribed morphine 100 mg/kg/
dose. After 2 months of in-hospital stay with intensive 
management, she had a cardiorespiratory arrest. No resus-
citation attempts were performed at the request of the 
parents.
2. Imaging
Cephalic displacement of bowel loops can be observed in 
thoracoabdominal radiographs, along with opacity of the 
pelvic cavity, intestinal dilated loops and decreased lung 
volume because of diaphragm elevation. Radiopacity of 
the abdomen increased over time in relation to the in-
crease of the ascitic fluid. Ribs are horizontalized and the 
heart shadow is enlarged. (Figure 1).
The abdominal ultrasound shows heterogeneous liver 
echogenicity, microlobulated edges, and a portal vein di-
ameter of 4.8 mm. Portal flow was hepatopetal of 26 
cm/s, there were collateral vessels with helical flow in 
the hilium.The hepatic artery had an IR of 0.9 and hepatic 
veins were permeable. The ultrasonogram conclusion was 
chronic liver damage, and portal hypertension with prob-
able portal vein cavernomatous transformation (Figure 2).
Head computed tomography (CT) showed increased 
depth of sulci and fissures, increased compensatory vol-
ume of the ventricular system and an arachnoid cyst. 
There was no evidence of hemorrhage or ischemia.
3. Case presentation
The syndromatic diagnoses were:
• Syndrome of portal hypertension, intrahepatic type: 
ascites, collateral vessels, ultrasonographic finding of 
suprahepatic and portal vein permeability.
• Cholestatic syndrome: jaundice and serum direct biliru-
bin greater than 2 mg/dl.
• Systemic inflammatory response syndrome: fever, tach-
ycardia, and leukocytosis.
• Encephalopathic syndrome: disturbance in the sleep 
pattern, irritability and decreased alertness, with no 
focal neurologic signs.
Table 3 Renal function tests.
 BUN Creat Na K Cl Ca P Mg
Blood 7.5 mg/dl 0.5 mg/dl 146 mEq/l 4.1 mEq/l 101 mEq/l 8.3 mg/dl 3.7 mg/dl 1.9 mg/dl
Urine 204 mg/dl 10.2 mg/dl 50 mEq/l 20.9 mEq/l 54 mEq/l 9.3 mg/dl 36.3 mg/dl
Urianalysis Cetone + Glucose +   
BUN, blood urea nitrogen; Creat, creatinine; Na, sodium; K, potassium; Cl, chloride; Ca, calcium; P, phosphorus; Mg, magnesium.
Figure 1 Simple thoracoabdominal X-rays. A. Displaced bowel loops. B. Horizontalization of ribs. C. Enlarged heart cavities.
A B C
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• Hemorrhagic syndrome: Based on bleeding from punc-
ture sites, endotracheal tube, and gastric drainage, 
bleeding gums, low hemoglobin and hematocrit, throm-
bocytopenia and increased clotting times.
• Respiratory distress syndrome: Based on intercostal re-
tractions, nasal flaring and thoracoabdominal dissocia-
tion.
• Abdominal compartment syndrome: Based on increased 
waist circumference and intra-abdominal pressure with 
impaired renal function.
Nosological diagnoses were:
• Hepatic encephalopathy based on neurological impair-
ment and hyperammonemia.
• Hepatic impairment based INR> 1.5 without improve-
ment after vitamin K administration, hypoglycemia, 
liver encephalopathy and hypoalbuminemia.
• Vitamin D insufficiency given vitamin D concentration 
of 21-29 ng/dl.
• Sepsis based on inflammatory response syndrome, ab-
dominal manifestations and positive blood cultures.
• Proximal tubulopathy given the glycosuria, hypophos-
phatemia, hypokalemia and hyperphosphaturia.
• Prerenal renal failure based on elevated serum creati-
nine, urea and FeNa of 0.6%
• Disseminated intravascular coagulation based on the 
hemorrhagic syndrome, thrombocytopenia, prolonged 
clotting times and decreased fibrinogen.
• Septic shock based on evidence of systemic inflamma-
tory response, hypotension, cold extremities, weak 
pulses and need of norepinephrine infusion.
• Multiple organ failure: neurological, cardiovascular, 
respiratory, hematological, hepatic and renal dysfunc-
tion.
Regarding the etiology of liver failure, bile canalicular 
and structural anomalies were unlikely because absent 
acholic or hypocholic stools, or choluria. Common infec-
tious causes of liver disease were ruled out, as serology 
was negative for hepatitis A, B and C, cytomegalovirus, 
Epstein-Barr virus, toxoplasma, rubella and HIV. Some less 
common etiologies that were not discarded were ECHO vi-
rus, Coxsackie virus, adenovirus, parvovirus and chicken-
pox. Hypothyroidism was also ruled out.
Liver disease of rapid progression to liver failure, devel-
opmental delay, tubulopathy and bilateral nuclear cata-
ract pointed to a metabolic disease. Fatty acid oxidation 
disorders were ruled out by ketonuria and normal BUN. A 
disorder of carbohydrate metabolism was unlikely since, 
while hemodynamically stable, there was no hypoglyce-
mia, metabolic acidosis or hyperlactatemia. Galactose 
quantification, urine reducing substances and liver biopsy 
were not available.
Respiratory alkalosis, ketonuria and increased ammonia 
up to 100 mmol/l suggested a defect in the urea cycle, but 
we could not confirm the deficiency of a specific enzyme. 
Furthermore, although amino acid profile was described 
as normal, succinyl acetone and urine organic acids were 
unavailable to rule out an aminoacidopathy.
As discussed above, the diagnostic possibilities were ga-
lactosemia, glycogenosis, tyrosinemia and an urea cycle 
disorder. Moreover, given the normal levels of gamma-glu-
tamyltranspeptidase, other alternatives were impaired 
synthesis of bile acids or progressive familial intrahepatic 
cholestasis.
It is worth noting that this patient had also failure to 
thrive (height for age at birth of 98% reduced to 89% at 5 
months of age), and also suffered severe malnutrition ac-
cording to WHO criteria for patients aged 6 to 60 months 
(weight for height less than 70%).
This patient probably had spontaneous bacterial peri-
tonitis on admission to the emergency room since she 
had a waist circumference 7 cm larger than in the first 
assessment, progressive jaundice, increased direct biliru-
bin and prolonged clotting times. To corroborate this di-
agnosis a paracentesis and peritoneal fluid culture were 
needed.
Hyponatremia in patients with liver disease and ascites 
is usually dilutional, because of renal retention of sodium 
and water. The main indications for hyponatremia correc-
tion are neurological symptoms and serum sodium less 
than 120 mEq/l. Fluid restriction is the most important 
action to increase serum sodium concentration. When hy-
pokalemia is associated to hyponatremia, as in this case, it 
should be corrected.
Refractory ascites is defined as the one which cannot 
be mobilized or reappears early after its treatment. It oc-
curs in 5-10% of patients, and is subdivided into two 
groups: diuretic resistant ascites and diuretic intractable 
ascites. This patient was in the latter group, since she pro-
gressed to kidney failure that contraindicated treatment 
with diuretics at high doses.
During her evolution, the patient had increased creati-
nine with no improvement after volume expansion with 
crystalloid fluids and albumin infusion. Hepatorenal syn-
drome should be suspected in cirrhotic patients with as-
cites who do not have renal parenchymal disease and have 
urinary sodium of 6 mmol/l. However, the patient did not 
meet the criteria for diagnosis because she had received 
Figure 2 Liver ultrasound showing increased echogenicity, 
peritoneal fluid collection and distended gallbladder with 
thickened walls.
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nephrotoxic drugs and serum creatinine was below 
1.5 mg/dl.
Final diagnoses were:
• Liver disease, probably secondary to an inborn error of 
metabolism
• Intrahepatic portal hypertension
• Acute liver failure
• Grade III hepatic encephalopathy
• Intractable ascites
• Sepsis with an abdominal origin
• Severe acute malnutrition
• Growth retardation of moderate intensity
• Developmental delay
4. Pathology
This was a necropsy of an infant with generalized jaun-
dice, portal hypertension, abdominal distension due to 
ascites, collateral vessels in thorax and abdomen, and re-
duced muscle mass. Peritoneal clear fluid was found (950 
ml) in the abdominal cavity. There was an epicardial 
bleeding.
The liver was enlarged, green colored an with a micro-
nodular surface; transversal serial sections showed regen-
erative nodules with a diameter smaller than 3 mm, 
multifocal areas of recent necrosis and dilatation of intra-
hepatic portal veins.(Figure 3). Histopathological examina-
tion showed micronodular liver cirrhosis. Regeneration 
nodules were surrounded by thin layers of fibrosis and nu-
merous cholangioles, some with bile plugs in their lumen. 
There was evidence of recent and past extensive necrosis 
of hepatocytes, mainly centrilobular, associated with 
macrovesicular steatosis and canalicular hepatocellular 
cholestasis (Figure 4). There were not hypereosinophilic 
hepatocytes due to the intense and chronic damage. The 
findings were consistent with those described in depletion 
of mitochondrial DNA (mtDNA) syndrome1. Immunohisto-
chemmical staining for cytokeratin-7 (CK7) showed intense 
canaliculi proliferation in the periphery of regeneration 
nodules and an abnormal expression of CK7 in hepatocyte 
cytoplasm highlighting the extensive hepatocytes loss 
(Figure 5). Iron storage was noticed in hepatocytes and 
Kupffer cells. Transmission electron microscopy showed 
hepatocytes with enlarged cytoplasm and an increased 
number of mitochondria which displaced the nucleus and 
other organelles. These atypical mitochondria had irregu-
Figure 3 Micronodular cirrhosis and severe cholestasis.
Figure 4 A. Photomicrograph showing regenerative nodules surrounded by thin bands of fibrosis (Masson 50X). B. Hepatocytes with 
cytoplasmic vacuolation and cholestasis. There is cholangiole proliferation in the periphery of regeneration nodules (HE 100X).
A B
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lar shapes and sizes, with an increased matrix volume of 
granular appearance and cristae decreased in number and 
displacement to the periphery (Figure 6). In other areas 
there were bile deposits and myelin-like structures which 
pointed to the diagnosis of a mitochondrial disease. Some 
authors suggest that these ultrastructural findings are 
characteristic of mtDNA depletion syndrome. Patients 
with the mutation MPV17 located on 2p24.1 show clinical 
and histopathological findings similar to this patient.1-4 
However, it is necessary to perform molecular biology 
tests to confirm this mutation.
The brain was atrophic with reduced weight (750 g vs. 
810 g), deep sulci and narrow gyri, exvacuo dilatation of 
lateral ventricles and decreased white matter. No altera-
tions in gray basal ganglia or cerebellum were observed. 
Microscopic examination showed the presence of Alzhei-
Figure 5 A. Cholangiole proliferation with expression of CK7 at the periphery of the lobule. B. Regeneration nodule with aberrant 
expression of CK7 in hepatocytes (arrow). Cholangioles highlighted by cytoplasmic expression of CK7 (IHC).
Figure 6 A. Three hepatocytes with increased number of mitochondria. B. Zoom of the cytoplasm showing pleomorphic 
mitochondria and cristae displaced to the periphery (arrow).
A B
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mer type 2 astrocytes in the cortex, which were related to 
the patient´ s liver failure. Medulla had areas of encephalo-
malacia with vascular proliferation and myelin vacuolation 
(Figure 7).
The kidneys showed medullary congestion; as an inde-
pendent finding, the right kidney had double collecting 
system. Histological sections showed lobulated parenchy-
ma, extensive nephrocalcinosis and normal glomeruli. The 
most important finding was proximal tubules dilatation. 
Epithelial cells showed large vacuolated cytoplasm with 
preserved luminal border. Ultrastructural findings were 
similar to those found in hepatocytes´  mitochondria and 
Figure 7 A. Enlarged lateral ventricles with data of cerebral parenchyma atrophy. B. Medulla with areas of encephalomalacia 
(arrow). C. Neuropil vacuolation and loss of myelin. D. Vascular proliferation.
Figure 8 A. Panoramic photomicrograph showing a nodular pattern of the renal cortex with enlarged tubular lumen and 
calcifications (HE 100X). B. Proximal tubules with cytoplasm vacuolation and lumen dilatation (HE 400X).
A B
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were responsible of proximal tubulopathy (Figure 8).5 Skel-
etal muscle was morphologically normal.
The most frequent type of mtDNA depletion syndrome 
is the hepatocerebral, which starts in the neonatal period, 
is progressive and lethal by the first year of life because of 
liver failure (Table 4). This syndrome is considered as a 
defect in mtDNA maintenance due to an impaired commu-
nication between the nuclear and mitochondrial DNA.2
Other findings were viral pneumonia with diffuse alveo-
lar damage, numerous giant cells, some with intracyto-
plasmic eosinophilic inclusions surrounded by a clear halo; 
electron microscopy analysis of inclusions showed electro-
dense filamentous structures consistent with respiratory 
syncytial virus (Figure 9). The myocardium showed colli-
quative myocitolysis, cardiomyocyte hypertrophy, and 
morphological data of multiorganic shock.
4.1. Final diagnoses
Mitochondrial DNA depletion syndrome, type hepatocere-
bral with proximal tubulopathy.
4.2. Concomitant alterations
• Hepatomegaly 800 g vs. 276 g
• Ascites 950 ml
• Micronodular cirrhosis
• Hepatocellular canallicular and ductal cholestasis
• Macro and microvesicular hepatic steatosis and mild he-
mosiderosis
• Ultrastructural mitochondrialchanges in hepatocytes
• Cerebral atrophy 750 g vs. 810 g
• Moderate medullaencephalomalacia
• Bilateral nephromegaly
• Proximaltubulopathy with epithelial vacuolation and 
mitochondrial ultrastructural changes.
• Extensive nephrocalcinosis
• Giant cell viral pneumonia by respiratory syncytial vi-
rus.
• Acute diffuse alveolar damage
• Grade B pulmonary vascular disease
• Cardiomegaly 50 g vs. 41 g
• Myocardic colliquative myocytolysis
4.3. Other findings
• Abnormal lung lobation
• Double right collecting system
This condition could have been diagnosed with a liver 
biopsy, since there were characteristic histopathological 
and ultrastructural findings.
Figure 9 A. Lung with viral pneumonia signs. B. Alveoli are lined by giant multinucleated cells and there is lymphocytic infiltrate 
in alveolar septa. C. Giant multinucleate cell with eosinophilic cytoplasmic inclusions (arrows). D. Electronic microscopy showing 
filamentous inclusions compatible with respiratory syncytial virus.
Table 4 Pediatric mitochondrial depletion syndrome 
types.
• Myopathic (OMIM #609560)
• Encephalomyopathic (OMIM #612073)
• Hepatocerebral (OMIM #251880)
A
C
B
D
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5. Final comments
5.1. Department of Genetics
The human genome can be divided into two groups: the 
nuclear genome and the mitochondrial genome. The nu-
clear genome has approximately 26 thousand genes, while 
the mitochondrial has 37 genes. Thirteen mitochondrial 
genes encode proteins that are part of the respiratory 
chain, the site of ATP production by oxidative phospho-
rylation.1 There is an important communication and inter-
action between the nuclear and mitochondrial genomes. 
There are some genes in nuclear DNA which encode pro-
teins responsible of maintenance, replication and tran-
scription of mtDNA; thus, the proper function of both 
genomes is necessary to mtDNA maintenance, and there-
fore, for ATP generation.6 Mitochondrial diseases are a 
group of multisystemic disorders, which frequently affect 
the central and peripheral nervous system; they are 
caused by different mutations located both in the mito-
chondrial and nuclear genomes. The prevalence of these 
diseases is 1 in 5,000 individuals.7 Clinical manifestations 
may occur in any organ or tissue, at any age and with any 
inheritance mechanism (Table 4). Due to the complexity 
of these diseases, diagnostic criteria and diagnostic prob-
ability scales have been developed in order to establish 
degrees of certainty for the existence of a mitochondrial 
dysfunction, as the modified Wolf scale (Table 5).8
Recently, new molecular techniques for mutation iden-
tification have been implemented, such as second genera-
tion sequencing, since mtDNA and nuclear DNA mutations 
cause similar signs and symptoms. The mtDNA depletion 
syndrome is a heterogeneous group of disorders caused by 
the decrease in the number of copies of mtDNA because of 
mutations in nuclear genes encoding proteins responsible 
for replication and maintenance of mtDNA. They have an 
autosomal recessive inheritance pattern and genetic het-
Table 5 Modified Wolf scale.
A. Myopathic 
manifestations
B. Central nervous 
system manifestations
C. Multisystemic 
manifestations
D. Laboratory and imaging 
manifestations
E. Morphologic 
characteristics
Ophtalmoplegia
Myopathic face
Exercise intolerance
Weakness
Rhabdomyolysis
Abnormal 
electromyogra-phy
Developmental delay
Loss of developmental 
milestones
Stoke like events
Migraine
Seizures
Myoclonic jerks
Cortical blindness
Pyramidal signs
Extrapyramidal signs
Brainstem dysfunction
Hematologic
Gastrointestinal
Endocrinologic
Cardiac
Renal
Vision
Hearing
Neuropathy
Familial recurrence
Increased lactate
Increased lactate/piruvate 
ratio
Increased alanine
High CSF lactate
High CSF proteins
High CSF alanine
Increased tricarboxylic acid 
excretion
Methylmalonic aciduria
Stroke like images
MR images of Leigh 
syndrome
MR with increased lactate 
by spectroscopy
Ragged red fibers
COX-negative fibers
Decreased COX 
staining
SDH Positive vessels
Abnormal 
mitochondria by 
electronic 
microscopy
CSF, cerebrospinal fluid; MR, magnetic resonance; COX, cytochrome C oxidase; SDH, succinate dehydrogenase.
erogeneity; i.e., mutations in different genes can cause 
the mtDNA depletion syndrome.9,10
In summary, mtDNA depletion syndrome should be con-
sidered when a newborn or infant presents with hypogly-
cemia, hyperlactatemia and hyperbilirubinemia. 
Ultrastructural mitochondrial findings in a liver biopsy 
may orient the diagnosis of mtDNA depletion syndrome. 
However, molecular biology studies are required for an ac-
curate diagnosis.
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